NCT02756546View on ClinicalTrials.gov

Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

December 31, 2015

Conditions
Systemic Lupus Erythematosis
Interventions
DRUG

Cyclophosphamide

DRUG

Hydroxychloroquine

DRUG

Hydrocortisone

All Listed Sponsors
lead

Cairo University

OTHER

NCT02756546 - Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis | Biotech Hunter | Biotech Hunter